# Revaccination With PPS23 Boosted or Not by PCV13 in Splenectomised Patients.

> **NCT03873727** · PHASE2 · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 39 (actual)

## Conditions studied

- Splenectomised Patients

## Interventions

- **BIOLOGICAL:** Prevenar13 (PCV13) and Pneumovax (PPS23)
- **BIOLOGICAL:** Placebo / Pneumovax (PPS23)
- **BIOLOGICAL:** Blood sample

## Key facts

- **NCT ID:** NCT03873727
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08-27
- **Primary completion:** 2023-06
- **Final completion:** 2024-06
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2022-10-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03873727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03873727, "Revaccination With PPS23 Boosted or Not by PCV13 in Splenectomised Patients.". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03873727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*